Heart failure rehospitalization

1 paper1 finding

Humans1

Associations

1

SGLT2 inhibitors

downin humans1HR 0.64

1 study

SGLT2 inhibitors lower the risk of heart failure rehospitalization in humans (HR 0.64, 95% CI 0.42-0.97).
“HF rehospitalization (hazard ratio, 0.64 [95% CI, 0.42-0.97]; P=0.037)”
Humansacute heart failure with high comorbidity1 yearn = 496
Efficacy and Safety of SGLT2 Inhibitors in Heart Failure: Observational Evidence in Geriatric Patients-AGING-HF
Circulation. Heart failure20 Aug 2025

More on SGLT2 inhibitors

Latest

2 in 12 months

Revista Espanola de Cardiologia8 Sep

Prognostic impact of an extravascular congestion score and its interaction with SGLT2 inhibitor therapy in patients hospitalized for acute heart failure

Cohort study of 821 peopleBiomarkers

Frontiers in Cardiovascular Medicine5 Aug

Long-term SGLT2 inhibitor therapy improves myocardial strain and diastolic function in HFpEF: a retrospective study linking functional recovery to reduced myocardial fibrosis

Cohort study of 185 peopleSGLT2 inhibitors

Circulation Heart Failure20 Aug

Efficacy and Safety of SGLT2 Inhibitors in Heart Failure: Observational Evidence in Geriatric Patients-AGING-HF

Cohort study of 496 peopleSGLT2 inhibitors